Regier, DA, Farmer, ME, Rae, DS, Locke, BZ, Keith, SJ, Judd, LL, et al. Comorbidity of mental disorders with alcohol
and other drug abuse. Results from the Epidemiologic Catchment Area (ECA)
1990; 264: 2511–8.
Cantwell, R, Brewin, J, Glazebrook, C, Dalkin, T, Fox, R, Medley, I, et al. Prevalence of substance misuse in
first-episode psychosis. Br J Psychiatry
1999; 174: 150–3.
Van Mastrigt, S, Addington, J, Addington, D. Substance misuse at presentation to an early
psychosis program. Soc Psychiatry Psychiatr
Lambert, M, Conus, P, Lubman, DI, Wade, D, Yuen, H, Moritz, S, et al. The impact of substance use disorders on
clinical outcome in 643 patients with first-episode
psychosis. Acta Psychiatr Scand
2005; 112: 141–8.
Barnes, TRE, Mutsatsa, SH, Hutton, SB, Watt, HC, Joyce, EM. Comorbid substance use and age at onset of
schizophrenia. Br J Psychiatry
2006; 188: 237–42.
Wade, D, Harrigan, S, Edwards, J, Burgess, PM, Whelan, G, McGorry, PD. Substance misuse in first-episode psychosis:
15-month prospective follow-up study. Br J
2006; 189: 229–34.
Larsen, TK, Melle, I, Auestad, B, Friis, S, Haahr, U, Johannessen, JO, et al. Substance abuse in first-episode
non-affective psychosis. Schizophr Res
Barnett, JH, Werners, U, Secher, SM, Hill, KE, Brazil, R, Masson, K, et al. Substance use in a population-based clinic
sample of people with first-episode psychosis. Br
2007; 190: 515–20.
Veen, ND, Selten, JP, van der Tweel, I, Feller, WG, Hoek, HW, Kahn, RS., Cannabis use and age at onset of
schizophrenia. Am J Psychiatry
2004; 161: 501–6.
Addington, J, Addington, D. Effect of substance misuse in early
psychosis. Br J Psychiatry
1998; 172 (suppl 33):
Linszen, DH, Dingemans, PM, Lenior, ME. Cannabis abuse and the course of recent-onset
schizophrenic disorders. Arch Gen
1994; 51: 273–9.
Grech, A, Van Os, J, Jones, PB, Lewis, SW, Murray, RM. Cannabis use and outcome of recent onset
psychosis. Eur Psychiatry
2005; 20: 349–53.
Wade, D, Harrigan, S, McGorry, P, Burgess, PM, Whelan, G. Impact of severity of substance use disorder on
symptomatic and functional outcome in young individuals with
first-episode psychosis. J Clin
2007; 68: 767–74
Kay, SR, Fiszbein, A, Opler, LA. The positive and negative syndrome scale (PANSS) for
schizophrenia. Schizophr Bull
1987; 13: 261–76.
Beck, AT, Ward, CH, Mendelson, M, Mock, J, Erbaugh, J. An inventory for measuring
depression. Arch Gen Psychiatry
1961; 4: 561–71.
Jablensky, A, Sartorius, N, Ernberg, G, Anker, M, Korten, A, Cooper, JE, et al. Schizophrenia: manifestations, incidence and
course in different cultures. A World Health Organization ten-country
study. Psychol Med Monogr Suppl
Endicott, J, Spitzer, RL, Fleiss, JL, Cohen, J. The Global Assessment Scale. A procedure for
measuring overall severity of psychiatric disturbance.
Arch Gen Psychiatry
1976; 33: 766–71.
McGuffin, P, Farmer, A, Harvey, I. A polydiagnostic application of operational criteria
in studies of psychotic illness. Development and reliability of the
OPCRIT system. Arch Gen Psychiatry
1991; 48: 764–70.
World Health Organization. The ICD–10
Classification of Mental and Behavioural Disorders: Clinical Descriptions
and Diagnostic Guidelines. WHO,
Sevy, S, Robinson, DG, Holloway, S, Alvir, JM, Woerner, MG, Bilder, R, et al. Correlates of substance misuse in patients
with first-episode schizophrenia and schizoaffective
disorder. Acta Psychiatr Scand
2001; 104: 367–74.
Verdoux, H, Lengronne, J, Liraud, F, Gonzales, B, Assens, F, Abalan, F, et al. Medication adherence in psychosis: predictors
and impact on outcome. A 2-year follow-up of first-admitted
subjects. Acta Psychiatr Scand
2000; 102: 203–10.
Coldham, EL, Addington, J, Addington, D. Medication adherence of individuals with a first
episode of psychosis. Acta Psychiatr
2002; 106: 286–90.
Startup, M, Jackson, MC, Bendix, S. The concurrent validity of the Global Assessment of
Functioning (GAF). Br J Clin Psychol
2002; 41: 417–22.
Sorbara, F, Liraud, F, Assens, F, Abalan, F, Verdoux, H. Substance use and the course of early psychosis: a
2-year follow-up of first-admitted subjects. Eur
2003; 18: 133–6.
Addington, J, Addington, D. Patterns, predictors and impact of substance use in
early psychosis: a longitudinal study. Acta
2007; 115: 304–9.
Margolese, HC, Carlos Negrete, J, Tempier, R, Gill, K. A 12-month prospective follow-up study of patients
with schizophrenia-spectrum disorders and substance abuse: changes in
psychiatric symptoms and substance use. Schizophr
Res. 2006; 83:
Malla, A, Norman, R, Bechard-Evans, L, Schmitz, N, Manchanda, R, Cassidy, C. Factors influencing relapse during a 2-year
follow-up of first-episode psychosis in a specialized early intervention
service. Psychol Med
Manchanda, R, Norman, RM, Malla, AK, Harricharan, R, Northcott, S. Persistent psychoses in first episode
patients. Schizophr Res
2005; 80: 113–6.
Dunnell, K. The changing demographic picture of the UK: national
statistician's annual article on the population.